Multiple Choice
A new portable cholesterol-measuring device is being developed for use in medically underserved communities. During clinical trials of an early prototype, a patient's cholesterol level is found to be 200 mg/dL, 201 mg/dL, and 200 mg/dL on 3 separate measurements of the same blood sample. Using the gold standard measurement method, the same sample is found to have a cholesterol level of 260 mg/dL. Which of the following descriptions best characterizes the new cholesterol-measuring device?
A) High accuracy; high precision
B) High accuracy; low precision
C) High sensitivity; low specificity
D) Low accuracy; high precision
E) Low accuracy; low precision
F) Low sensitivity; high specificity
Correct Answer:

Verified
Correct Answer:
Verified
Q107: Zeracizumab is an experimental angiogenesis inhibitor targeting
Q108: A pediatrician examines a population of 1,000 children
Q109: Researchers are interested in the association between
Q110: A pediatric cardiologist decides to determine whether
Q111: A 45-year-old woman comes to the office
Q113: An 89-year-old man is brought to a
Q114: Researchers studying the effects of hormone replacement
Q115: A prospective cohort study was conducted to
Q116: Researchers want to study the effects of labyrinthectomy
Q117: The figure below shows the estimated incidence